Lyka Labs jumps after getting CDSCO nod for diabetic drug

Lyka Labs rallied 4.65% to Rs 156.50 after the company received the Central Drug Standard Control Organisation (CDSCO) approval for manufacturing and marketing Pregabalin Gel for the use in patients with Diabetic Neuropathic Pain.